Deutsch, Y. E., Dammrich, D. J., Fabregas, J. C., Pimentel, A., Stefanovic, A., & Hoffman, J. E. (2013). Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population. In Blood (Vol. 122, pp. 5399–5399). American Society of Hematology. https://doi.org/10.1182/blood.v122.21.5399.5399

Deutsch, Yehuda E., Daniel J. Dammrich, Jesus C. Fabregas, Agustin Pimentel, Alexandra Stefanovic, and James E. Hoffman. “Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population.” In Blood, 122:5399–5399. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.5399.5399.

Deutsch YE, Dammrich DJ, Fabregas JC, Pimentel A, Stefanovic A, Hoffman JE. Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population. In: Blood. American Society of Hematology; 2013. p. 5399–5399.

Deutsch, Yehuda E., et al. “Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population.” Blood, vol. 122, no. 21, American Society of Hematology, 2013, pp. 5399–5399. Crossref, doi:10.1182/blood.v122.21.5399.5399.

Deutsch YE, Dammrich DJ, Fabregas JC, Pimentel A, Stefanovic A, Hoffman JE. Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population. Blood. American Society of Hematology; 2013. p. 5399–5399.